Hard to believe ADXS is within a dollar of its 52 week low while the biotech sector is hovering around its 52 high and the broad market is around all time highs. We are down 75% from our $30 high two years ago. This needs to be addressed. God forbid what ADXS would be trading at if we actually had a market pullback. Hopefully, Dan is feeling the heat, but one might interpret from his references on page 4 of the presentation that he thinks the current stock price and performance has been just fine.